scholarly journals Retrochorial hematoma: principles of complex therapy

2012 ◽  
Vol 61 (4) ◽  
pp. 104-108 ◽  
Author(s):  
Lilia Dmitriyevna Solovova ◽  
Olga Igorevna Lineva ◽  
Yulia Anatolyevna Artych ◽  
Anna Vladimirovna Kazakova ◽  
Inna Alekseyevna Berdnikova

In the article there are the hormonal and immunological aspects of pathogenesis retroсhorial hematomas in women with treatened abortion, clinic and diagnosis of this complication. Analysis of efficiency complex therapy with using of Dydrogesterone and Wobenzym were carried out among 80 pregnant women in comparison with standard method of therapy.

2016 ◽  
Vol 3 (3) ◽  
pp. 370-373
Author(s):  
Дегтяревская ◽  
T. Degtyarevskaya

Objective of research: The study of eosinophilic reaction in blood at experimental dictycaulosis of young sheep and after providing the complex therapy. Materials and methods: The research was conducted in August- September 2013at an experimental farm «Kurilovo» in Podolsk district of Moscow region. Six mongrel lambs at 4–5 months of age, free from infection, and 18 lambs experimentally infected with Dictyocaulus filarial at gtye dose of 1000 larvae per head were investigated. 30 days after invasion, lambs were divided into 3 equal groups (6 head in each) and kept under conditions excluding the possibility of spontaneous invasion. Lambs of the first group free from infection, served as controls and did not receive the drug. Infected animas of the second group were not treated and served as controls. Lambs of the third group received Alben as 20% granulated powder at the dose of 5 mg a.i./kg (0,25 g of granules per 10 kg of body weight); the fourth group of lambs received Alben at the same dose and subcutaneously T-activin at the dose of 2 mkg/kg once a day on the 1st , 3rd and 7th day of invasion, and В-activin at the dose of 5 mkg/ kg intramusculary once a day during 5 days. Before the experiment and after 7, 15, 30 and 60 days of treatment, blood samples were taken from calves. Trilon B was used as anticoagulant. Blood eosinophil levels were measured by the standard method. Results and discussion: Persistent blood eosinophilia was determined at experimental dictycaulosis in lambs. The level of eosinophils cannot be fully restored by dehelmintization with Alben. The full restoration of the quantity of eosinophils in blood of infected lambs occurs after the complex therapy with Alben in combination with T and В-activin.


2019 ◽  
pp. 104-109
Author(s):  
O. I. Marushkina

Aim:evaluation of efficacy of Multi-Gyn® Actigel application in the complex therapy of bacterial vaginosis (BV) and prevention of its recurrence in pregnant women.Patients and methods:87 patients of reproductive age were examined and treated with the diagnosis of «bacterial vaginosis, chronic recurrent course». 41 of them from the main group were given Multi-Gyn® Actigel at the 1st stage of treatment, while 46 women of the comparison group were given 2% clindamycin cream In order to restore vaginal microbiocenosis, a probiotic containing Lactobacillus casei rhamnosus spp. LCR35 was used in both groups at the second stage Clinical laboratory methods were used.Results:efficacy of Multi-Gyn® Actigel application in complex therapy of BV and prevention of its recurrences in non-pregnant women was proved. As a result of Multi-Gyn® Actigel prescription there were no complaints, pH level was normalized, almost complete absence of BV-associated microorganisms was achieved and lactobacillus pool preservation even in the distant period after treatment.Conclusion:Multi-Gyn® Actigel is an effective remedy for treatment of BV and prevention of its recurrence in non-pregnant patients, especially in the chronic recurrent course of the disease. This effect is achieved not only by eliminating anaerobic microorganisms, but also due to the persistent preservation of the lactobacillus pool.


Author(s):  
Е.А. Орлова ◽  
О.П. Виноградова ◽  
Е.М. Костина ◽  
Ю.А. Кандрашкина

Проблема особенностей течения аллергических заболеваний на фоне беременности, а также рациональные и безопасные подходы к их лечению находятся в фокусе пристального внимания специалистов. В статье представлена клинико-патогенетическая характеристика атопического дерматита у беременных женщин. Уделяется внимание принципам диагностики атопического дерматита при беременности. Ранняя диагностика особенно важна при наступлении беременности, поскольку у детей, рожденных в семье, где оба родителя страдают атопией, риск развития атопического дерматита равняется 75%. В первую очередь для профилактики возможных обострений атопического дерматита у беременных необходимо решить вопрос с ликвидацией триггерных факторов и исключить контакт с аллергенами, особое внимание следует уделять гипоаллергенной диете. Рассматриваются вопросы выбора тактики ведения и терапии дерматоза с учетом клинических исследований, оценки степени риска для беременной и плода. Обсуждаются особенности применения эмолентов, топических глюкокортикостероидов, топических противозудных средств, седативных и антигистаминных препаратов в составе комплексной терапии беременных с атопическим дерматитом. The problem of the peculiarities of the course of allergic diseases during pregnancy, as well as rational and safe approaches to their treatment, is in the focus of close attention of specialists. The article presents the clinical and pathogenetic characteristics of atopic dermatitis in pregnant women. Attention is paid to the principles of diagnosis of atopic dermatitis during pregnancy. Early diagnosis is especially important when pregnancy occurs, since children born to a family where both parents have atopy have a 75% risk of developing atopic dermatitis. First of all, for the prevention of possible exacerbations of atopic dermatitis in pregnant women, it is necessary to resolve the issue of eliminating trigger factors and exclude contact with allergens, special attention should be paid to a hypoallergenic diet. The issues of the choice of tactics of management and therapy of dermatosis are considered, taking into account clinical studies, assessment of the degree of risk for the pregnant woman and the fetus. The features of the use of emollients, topical glucocorticosteroids, topical antipruritic agents, sedatives and antihistamines as part of the complex therapy of pregnant women with atopic dermatitis are discussed.


2020 ◽  
Vol 0 (54) ◽  
pp. 55-62
Author(s):  
Д. Г. Коньков ◽  
Н. В. Адамчук ◽  
В. В. Кливак

1986 ◽  
Vol 67 (6) ◽  
pp. 450-451
Author(s):  
A. I. Nagovitsina ◽  
Z. S. Kornyaeva ◽  
Z. Ya. Soboleva ◽  
F. N. Ivshin ◽  
V. N. Borozdina

We observed 23 women who developed peritonitis after cesarean section. The average age of the patients was 28.9 years. There were 7 first-pregnant women and 16 second-pregnant women. The anamnesis revealed the presence of endogenous foci of infection in all the patients. Thus, flu, sore throat, acute respiratory infections were diagnosed in 20 women, pneumonia in 3; chronic pyelonephritis in 5, inflammatory uterine appendages in 6, rheumatism with mitral valve insufficiency in 1, Botkin disease in 1. Genuine pregnancy was preceded by abortions in 19 women, of whom 11 had formal abortions, 3 had criminal abortions, and 5 had spontaneous abortions at 10 to 25 weeks' gestation against a background of chronic pyelonephritis and inflammatory diseases of the uterine appendages.


Author(s):  
M.V. Shvechkova ◽  
◽  
I.I. Kukarskaya ◽  
R.N. Marchenko ◽  
I.I. Kuratcenko ◽  
...  

Introduction. Pregnant women may be at increased risk for severe COVID-19 illness. Pregnant women are more likely to be hospitalized at ICU, needed the mechanical ventilation compared to nonpregnant women. The pregnant women are currently excluded from the most of the clinical trials of COVID-19 drug therapy. This limits the formulation of appropriate recommendations for the treatment of pregnant women with SARS-CoV-2 infection. Building on the experience of the effective use of surfactant therapy for influenza A/H1N1 treatment of pregnant women with COVID-19, the domestic/local drug Surfactant BL was included in the complex therapy. The objective. To evaluate the effectiveness of surfactant therapy in the integrated treatment of severe COVID-19 pneumonia of pregnant women and postpartum women. Materials and methods. The study included 69 pregnant and postpartum women with severe COVID-19 pneumonia. All ofthem received antiviral, anticoagulant and anti-inflammatory therapy. 47 patients (group 1) with an initially more severe course of the disease received inhalations with Surfactant BL in 1–2 days after admission to the intensive care unit, 22 patients (group 2) were prescribed surfactant therapy for 4–5 days, due to the progression of respiratory failure. Surfactant BL was administered at a dose of 75 mg 2 times a day through a nebulizer for 2–5 days. Result. In group 1 patients, SpO2 recovered faster and dyspnea decreased. All patients of group 1 did not require mechanical ventilation; in group 2, 3 patients (14.3%) required mechanical ventilation. In the group of early use of surfactant therapy with CT control, in most cases, there was a positive trend (67.6%), in contrast to group 2 (37.5%). Stay in ICU conditions in group 1 was 8.6 days, in group 2 – 13.2 days. No lethal outcomes were observed with surfactant therapy in both groups. Conclusion. Early surfactant therapy against the background of complex therapy allows to avoid mechanical ventilation, reducing the length of stay of patients in the intensive care unit and preventing mortality from COVID-19 pneumonia.


2018 ◽  
pp. 60-63
Author(s):  
I. V. Savelyeva ◽  
O. V. Shirokova ◽  
E. A. Bukharova ◽  
I. B. Polyanskaya ◽  
E. G. Galyanskaya ◽  
...  

2018 ◽  
pp. 34-38
Author(s):  
A.V. Kaminskiy ◽  
◽  
T.V. Kolomiichenko ◽  
I.V. Rogava ◽  
◽  
...  

Obstetricians-gynecologists do not always pay sufficient attention to nausea and vomiting of pregnancy (NVP), sometimes its severity is underestimated and adequate treatment is not prescribed. The objective: to investigate the efficacy and safety of the complex therapy of NVP in pregnant women after ART, including a preparation of ginger extract with pyridoxine and psychotherapy. Materials and methods. Sixty pregnant women were examined after applying VRT, with mild manifestations of NVP. The main group consisted of 30 women, with Emegest (ginger and pyridoxine extract) and psychotherapy used in NVP therapy, and a comparison group of 30 women who only adhered to recommendations on changes in diet and life. The presence of the syndrome of autonomic dysfunction was established using the A.M.Veyn questionnaire. For self-assessment of the level of reactive and personal anxiety, testing was carried out according to the method of Ch.D. Spilberger, Yu.L. Khanin. The quality of life was assessed using the SF-36 questionnaire. Results. The use of recommended NVP therapy in pregnant women after ART makes it possible to improve the condition of women already for 2–3 days, and in 2 weeks of treatment it is essential to reduce or even eliminate the symptoms of NVP. Complex therapy reduces the severity of the syndrome of autonomic dysfunction and the level of personal and situational anxiety, which, against the background of improving the overall condition, positively affects the quality of life. The applied therapy had no side effects or complications, positively influenced the further course of pregnancy and the condition of the fetus and the newborn, in particular, the frequency of preeclampsia is decreased by half and the birth asphyxia by 1.5. Conclusion. The safety and efficacy of Emegest in the complex therapy of nausea and vomiting of pregnancy allows us to recommend its use in pregnant women after ART. Key words: nausea and vomiting of pregnancy, Emegest, auxiliary reproductive technologies, psychotherapy.


Sign in / Sign up

Export Citation Format

Share Document